Replies to post #188220 on Biotech Values

[dewophile]

15% IS good at this point given the time lag for many of ABBV's exclusivity contracts to take effect and the sometimes lengthy pre approval process for Rxs to work their way through the system
barclays however doesn't seem to think so they have a 35 dollar PT on ENTA